Analyst
Wells Fargo
Equibles does not estimate personal net worth.
Larry Beegelson is recorded as Analyst at Wells Fargo. Larry Beegelson has spoken on 4 earnings calls and 1 other investor event across 5 companies, most recently for Icu Medical Inc on September 10, 2026. Those appearances were for Icu Medical Inc (ICUI), Zimmer Biomet Holdings, Inc. (ZBH), Dexcom Inc (DXCM), Axogen, Inc. (AXGN) and Johnson & Johnson (JNJ). The companies whose calls Larry Beegelson spoke on are classified in the Healthcare sector.
“With us from the company, we have Vivek Jain, the chairman and CEO. As I said, it's gonna be a fireside chat. So if you have a question, just raise your hand.”
“Yvonne, you know the recon market question is coming, and you talked about healthy underlying trends. So, you know, when we aggregate the data, it looks like the recon market did slow in the first half of 26.”
“I just wanted to ask on type 2 non-insulin. So we did hear the RCT presentation is slated for ADA. Just wondering, could we see a publication before ADA, And do you plan to share any color on the trial results at the investor day?”
“Mike, you know, growth obviously accelerated here in Q1. Maybe a little bit more color on what drove the acceleration here. And with the new, you know, 20% plus, you know, guidance here, how are you thinking about the LRP of 15 to 20%?”
“Tim, sentiment in the medical device space is relatively low right now because of a number of headwinds and concerns. You posted a respectable growth rate this quarter, but it was slightly below the Q4 growth rate, And, you know, the comp in Q1 was relatively easy.”
Wells Fargo
Analyst
Transcript header (unverified)
ICUI
Medical Instruments & Supplies · Healthcare
DXCM
Medical Devices · Healthcare
AXGN
Medical Devices · Healthcare
Drug Manufacturers - General · Healthcare
